Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

H.G. Nusslein; R. Alten; M. Galeazzi; H.M. Lorenz; M.T. Nurmohamed; W.G. Bensen; G.R. Burmester; H.H. Peter; K. Pavelka; M. Chartier; C. Poncet; C. Rauch; M. Le Bars

doi:10.1186/s12891-015-0636-9

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

H.G. Nusslein, R. Alten, M. Galeazzi, H.M. Lorenz, M.T. Nurmohamed, W.G. Bensen, G.R. Burmester, H.H. Peter, K. Pavelka, M. Chartier, C. Poncet, C. Rauch, M. Le Bars

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	176
Journal	BMC Musculoskeletal Disorders
Volume	16
DOIs	https://doi.org/10.1186/s12891-015-0636-9
Publication status	Published - 2015

Access to Document

10.1186/s12891-015-0636-9

Cite this

Nusslein, H. G., Alten, R., Galeazzi, M., Lorenz, H. M., Nurmohamed, M. T., Bensen, W. G., Burmester, G. R., Peter, H. H., Pavelka, K., Chartier, M., Poncet, C., Rauch, C., & Le Bars, M. (2015). Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study. BMC Musculoskeletal Disorders, 16, [176]. https://doi.org/10.1186/s12891-015-0636-9

Nusslein, H.G. ; Alten, R. ; Galeazzi, M. ; Lorenz, H.M. ; Nurmohamed, M.T. ; Bensen, W.G. ; Burmester, G.R. ; Peter, H.H. ; Pavelka, K. ; Chartier, M. ; Poncet, C. ; Rauch, C. ; Le Bars, M. / Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study. In: BMC Musculoskeletal Disorders. 2015 ; Vol. 16.

@article{619a6d42afa74a6e9f63728e56fe3cec,

title = "Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study",

author = "H.G. Nusslein and R. Alten and M. Galeazzi and H.M. Lorenz and M.T. Nurmohamed and W.G. Bensen and G.R. Burmester and H.H. Peter and K. Pavelka and M. Chartier and C. Poncet and C. Rauch and {Le Bars}, M.",

year = "2015",

doi = "10.1186/s12891-015-0636-9",

language = "Undefined/Unknown",

volume = "16",

journal = "BMC Musculoskeletal Disorders",

issn = "1471-2474",

publisher = "BioMed Central",

}

Nusslein, HG, Alten, R, Galeazzi, M, Lorenz, HM, Nurmohamed, MT, Bensen, WG, Burmester, GR, Peter, HH, Pavelka, K, Chartier, M, Poncet, C, Rauch, C & Le Bars, M 2015, 'Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study', BMC Musculoskeletal Disorders, vol. 16, 176. https://doi.org/10.1186/s12891-015-0636-9

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study. / Nusslein, H.G.; Alten, R.; Galeazzi, M.; Lorenz, H.M.; Nurmohamed, M.T.; Bensen, W.G.; Burmester, G.R.; Peter, H.H.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.

In: BMC Musculoskeletal Disorders, Vol. 16, 176, 2015.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

AU - Nusslein, H.G.

AU - Alten, R.

AU - Galeazzi, M.

AU - Lorenz, H.M.

AU - Nurmohamed, M.T.

AU - Bensen, W.G.

AU - Burmester, G.R.

AU - Peter, H.H.

AU - Pavelka, K.

AU - Chartier, M.

AU - Poncet, C.

AU - Rauch, C.

AU - Le Bars, M.

PY - 2015

Y1 - 2015

U2 - 10.1186/s12891-015-0636-9

DO - 10.1186/s12891-015-0636-9

M3 - Article

C2 - 26228643

VL - 16

JO - BMC Musculoskeletal Disorders

JF - BMC Musculoskeletal Disorders

SN - 1471-2474

M1 - 176

ER -